Rocket Pharma is focused on developing gene therapies for rare diseases, particularly those affecting the heart and blood, such as Danon Disease and Arrhythmogenic Cardiomyopathy
Rocket Pharma is focused on developing gene therapies for rare diseases, particularly those affecting the heart and blood, such as Danon Disease and Arrhythmogenic Cardiomyopathy.
Rocket Pharma is focused on developing gene therapies for rare diseases, particularly those affecting the heart and blood, such as Danon Disease and Arrhythmogenic Cardiomyopathy
Rocket Pharma is focused on developing gene therapies for rare diseases, particularly those affecting the heart and blood, such as Danon Disease and Arrhythmogenic Cardiomyopathy.